Literature DB >> 18231852

Effect of melatonin and melatonylvalpromide on beta-amyloid and neurofilaments in N2a cells.

Xiao-Chuan Wang1, Yin-Chun Zhang, Nithiananda Chatterjie, Inge Grundke-Iqbal, Khalid Iqbal, Jian-Zhi Wang.   

Abstract

In the present study, we have studied the effect of melatonin (Mt) and melatonin derivative, i.e., melatonylvalpromide (Mtv), on cell viability, beta-amyloid (Abeta) production, cell morphology, and expression and phosphorylation of neurofilament proteins in wild-type murine neuroblastoma N2a (N2a/wt) and N2a stably transfected with amyloid precursor protein (N2a/APP) cell lines. The study used MTT assay, Sandwich ELISA, immunocytochemistry and Western blots techniques. The results showed that both Mt and Mtv could increase cell viability, but Mtv did so more effectively. The N2a/APP showed shorter and less amount of cell processes than N2a/wt, and Mtv but not Mt slightly improved the morphological changes in N2A/APP. Both Mt and Mtv suppressed the Abeta level in cell lysates, but the effect of Mtv was stronger than Mt. The immunoreaction to the non-phosphorylated neurofilament proteins probed by SMI32 and SMI33 were remarkably weaker in N2a/APP than N2a/wt, while the immunoreaction to the phosphorylated neurofilament proteins at SMI34 epitopes was slightly stronger in N2a/APP than N2a/wt, suggesting higher phosphorylation level of neurofilament proteins in N2a/APP. Treatment of the cells with Mt and Mtv increased the immunoreaction at SMI32 and SMI33 epitopes, while only Mtv but not Mt decreased the staining at SMI34 epitope, suggesting both Mt and Mtv promote dephosphorylation of neurofilament at SMI32 and SMI33 epitopes, while Mtv stimulates dephosphorylation of neurofilament at SMI34 epitope. These results suggest that Mtv may be a better candidate in arresting the intracellular accumulation of Abeta and protecting the cells from Abeta-related toxicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18231852     DOI: 10.1007/s11064-007-9563-y

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  37 in total

1.  The shorter amyloid cascade hypothesis.

Authors:  J Hardy
Journal:  Neurobiol Aging       Date:  1999 Jan-Feb       Impact factor: 4.673

2.  Age-related changes in serum melatonin in mice: higher levels of combined melatonin and 6-hydroxymelatonin sulfate in the cerebral cortex than serum, heart, liver and kidney tissues.

Authors:  Debomoy K Lahiri; Yuan-Wen Ge; Edward H Sharman; Stephen C Bondy
Journal:  J Pineal Res       Date:  2004-05       Impact factor: 13.007

Review 3.  Role of melatonin in Alzheimer-like neurodegeneration.

Authors:  Jian-zhi Wang; Ze-fen Wang
Journal:  Acta Pharmacol Sin       Date:  2006-01       Impact factor: 6.150

Review 4.  Plaques and tangles and the pathogenesis of Alzheimer's disease.

Authors:  Richard A Armstrong
Journal:  Folia Neuropathol       Date:  2006       Impact factor: 2.038

5.  Inhibition of Alzheimer beta-fibrillogenesis by melatonin.

Authors:  M Pappolla; P Bozner; C Soto; H Shao; N K Robakis; M Zagorski; B Frangione; J Ghiso
Journal:  J Biol Chem       Date:  1998-03-27       Impact factor: 5.157

6.  Kinetic characterization of the nitric oxide toxicity for PC12 cells: effect of half-life time of NO release.

Authors:  T Yamamoto; K Yuyama; K Nakamura; T Kato; H Yamamoto
Journal:  Eur J Pharmacol       Date:  2000-05-26       Impact factor: 4.432

Review 7.  An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease.

Authors:  M A Pappolla; Y J Chyan; B Poeggeler; B Frangione; G Wilson; J Ghiso; R J Reiter
Journal:  J Neural Transm (Vienna)       Date:  2000       Impact factor: 3.575

8.  Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells.

Authors:  Lyda M Rincón Castro; Michel Gallant; Lennard P Niles
Journal:  J Neurochem       Date:  2005-12       Impact factor: 5.372

Review 9.  Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease.

Authors:  Gunnar K Gouras; Claudia G Almeida; Reisuke H Takahashi
Journal:  Neurobiol Aging       Date:  2005-10       Impact factor: 4.673

10.  Tau protein function in living cells.

Authors:  D G Drubin; M W Kirschner
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more
  13 in total

Review 1.  Melatonin in Alzheimer's Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer's Neuropathology.

Authors:  Md Farhad Hossain; Md Sahab Uddin; G M Sala Uddin; Dewan Md Sumsuzzman; Md Siddiqul Islam; George E Barreto; Bijo Mathew; Ghulam Md Ashraf
Journal:  Mol Neurobiol       Date:  2019-06-17       Impact factor: 5.590

2.  Anti-amyloidogenic and anti-apoptotic role of melatonin in Alzheimer disease.

Authors:  Hongwen He; Weiguo Dong; Fang Huang
Journal:  Curr Neuropharmacol       Date:  2010-09       Impact factor: 7.363

3.  CD82-TRPM7-Numb signaling mediates age-related cognitive impairment.

Authors:  Yin Zhao; Tamas Kiss; Jordan DelFavero; Lu Li; Xing Li; Lu Zheng; Jie Wang; Chao Jiang; Jing Shi; Zoltan Ungvari; Anna Csiszar; Xin A Zhang
Journal:  Geroscience       Date:  2020-02-22       Impact factor: 7.713

4.  Expression of 1N3R-Tau isoform inhibits cell proliferation by inducing S phase arrest in N2a cells.

Authors:  Li Li; Zhi-Peng Xu; Gong-Ping Liu; Cheng Xu; Zhi-Hao Wang; Xiao-Guang Li; En-Jie Liu; Juan Zeng; Da-Min Chai; Wen-Long Yao; Jian-Zhi Wang
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

Review 5.  Melatonin in Alzheimer's disease.

Authors:  Li Lin; Qiong-Xia Huang; Shu-Sheng Yang; Jiang Chu; Jian-Zhi Wang; Qing Tian
Journal:  Int J Mol Sci       Date:  2013-07-12       Impact factor: 5.923

6.  Melatonin and abeta, macular degeneration and alzheimers disease: same disease, different outcomes?

Authors:  Bajic Vladan; Isabella Panfoli
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2012

7.  Comparison of the Effects of 13-cis Retinoic Acid and Melatonin on the Viabilities of SH-SY5Y Neuroblastoma Cell Line.

Authors:  Murat Tosun; Yasemin Soysal; Nuket Gocmen Mas; Hamit Selim Karabekir
Journal:  J Korean Neurosurg Soc       Date:  2015-03-20

8.  Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells.

Authors:  Li-Fang Zhang; Zhi-Wei Zhou; Zhen-Hai Wang; Yan-Hui Du; Zhi-Xu He; Chuanhai Cao; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2014-12-24       Impact factor: 4.162

9.  The beneficial effect of melatonin in brain endothelial cells against oxygen-glucose deprivation followed by reperfusion-induced injury.

Authors:  Juhyun Song; So Mang Kang; Won Taek Lee; Kyung Ah Park; Kyoung Min Lee; Jong Eun Lee
Journal:  Oxid Med Cell Longev       Date:  2014-07-14       Impact factor: 6.543

Review 10.  Regulation of Melatonin and Neurotransmission in Alzheimer's Disease.

Authors:  Jaydeep Roy; Ka Chun Tsui; Jonah Ng; Man-Lung Fung; Lee Wei Lim
Journal:  Int J Mol Sci       Date:  2021-06-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.